TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations

Table 1

Characteristics of the 48 CLL patients included in the study.

Parameter	Category	%
Age (years),; median (range)		65 (37–84)
Gender	Male	54
White blood cells (×109/L),; median (range)		24,980; (10,130–96,510)
Lymphocytes (×109/L),; median (range)		21,070; (5,900–86,320)
Hemoglobin (×109/L),; median (range)		13.6; (11.5–15.8)
Platelet (×109/L),; median (range)		176,500; (70,000–333,000)
Binet stage	A	67
	B	27
	C	6
Lactate; dehydrogenase	High	7
𝛽2 microglobulin	High	25
IGHV	Unmutated	45
FISH abnormality*	13q deletion	56
	11q deletion	15
	17p deletion	2
	Trisomy 12	17
	No FISH; abnormalities	29

∗Some patients have more than one cytogenetic aberration.